SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GAVIOLI, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.394
AS - Asia 7.128
EU - Europa 4.373
SA - Sud America 1.059
AF - Africa 158
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 27.136
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.097
SG - Singapore 2.768
CN - Cina 1.779
BR - Brasile 836
VN - Vietnam 821
PL - Polonia 765
UA - Ucraina 683
IT - Italia 676
DE - Germania 618
HK - Hong Kong 544
GB - Regno Unito 445
TR - Turchia 409
FI - Finlandia 267
FR - Francia 244
SE - Svezia 220
RU - Federazione Russa 149
BD - Bangladesh 145
IN - India 141
CA - Canada 139
JP - Giappone 134
MX - Messico 108
AR - Argentina 86
ID - Indonesia 82
BE - Belgio 72
NL - Olanda 65
ZA - Sudafrica 59
IQ - Iraq 51
ES - Italia 39
PK - Pakistan 35
CO - Colombia 31
VE - Venezuela 28
LT - Lituania 25
PH - Filippine 25
MY - Malesia 24
CL - Cile 23
MA - Marocco 23
SA - Arabia Saudita 23
EC - Ecuador 22
UZ - Uzbekistan 22
AE - Emirati Arabi Uniti 20
AU - Australia 18
IR - Iran 17
TN - Tunisia 17
CZ - Repubblica Ceca 16
PY - Paraguay 16
AT - Austria 15
AL - Albania 12
JO - Giordania 12
KE - Kenya 12
IE - Irlanda 11
JM - Giamaica 11
DZ - Algeria 10
EG - Egitto 9
OM - Oman 9
CR - Costa Rica 8
PA - Panama 8
PE - Perù 8
RO - Romania 8
KR - Corea 7
LB - Libano 7
SN - Senegal 7
TT - Trinidad e Tobago 7
KZ - Kazakistan 6
MD - Moldavia 6
NP - Nepal 6
UY - Uruguay 6
CH - Svizzera 5
ET - Etiopia 5
GR - Grecia 5
IL - Israele 5
KG - Kirghizistan 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
DO - Repubblica Dominicana 4
LY - Libia 4
RS - Serbia 4
TH - Thailandia 4
TW - Taiwan 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
AZ - Azerbaigian 3
HN - Honduras 3
HR - Croazia 3
NI - Nicaragua 3
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
LK - Sri Lanka 2
MT - Malta 2
NO - Norvegia 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
Totale 27.113
Salva come PNG Salva come JPEG
Città #
Singapore 1.752
Ashburn 1.590
Fairfield 1.283
Woodbridge 1.108
San Jose 905
Houston 897
Warsaw 757
Jacksonville 731
Ann Arbor 726
Chandler 684
Beijing 592
Santa Clara 570
Hong Kong 531
Seattle 515
Wilmington 456
Cambridge 439
Dallas 305
Los Angeles 271
Ho Chi Minh City 258
Ferrara 232
Izmir 231
New York 218
Hanoi 207
Nanjing 181
Munich 154
Princeton 149
San Diego 145
Tokyo 130
Lauterbourg 129
Boardman 108
Milan 101
São Paulo 92
Shanghai 91
Helsinki 83
The Dalles 79
Buffalo 77
Mexico City 74
Brussels 70
Shenyang 68
Council Bluffs 65
Hefei 63
Nanchang 56
Montreal 54
London 53
Orem 51
Turku 50
Dearborn 49
Bologna 47
Jakarta 47
Tianjin 47
Addison 45
San Mateo 45
Chicago 43
Da Nang 43
Haiphong 43
Changsha 42
Hebei 42
Bremen 38
Boston 37
Brooklyn 37
Jinan 37
Chennai 36
Falls Church 36
Atlanta 35
Frankfurt am Main 33
San Francisco 33
Toronto 32
Jiaxing 31
Phoenix 31
Stockholm 30
Amsterdam 29
Johannesburg 28
Mountain View 27
Porto Alegre 27
Rio de Janeiro 27
Rome 27
Guangzhou 26
Manchester 25
Denver 24
Dong Ket 23
Falkenstein 23
Poplar 23
Auburn Hills 21
Moscow 21
Tashkent 20
Belo Horizonte 19
Columbus 19
Zhengzhou 19
Norwalk 18
Brasília 17
Des Moines 17
Dhaka 17
Ningbo 17
Ardabil 16
Baghdad 16
Modena 16
Philadelphia 16
Redwood City 16
Ankara 15
Istanbul 15
Totale 18.944
Salva come PNG Salva come JPEG
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 409
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 364
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 284
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 276
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 273
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 262
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 260
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 259
Nafion®-containing solid lipid nanoparticles as a tool for anticancer pt delivery: preliminary studies 252
Arecoline tripeptide inhibitors of proteasome 247
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 245
Association between different anti-Tat antibody isotypes and HIV disease progression: Data from an African cohort 240
Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity 239
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 238
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 232
Biologically active platinum complexes containing 8-thiotheophylline and 8-(methylthio)theophylline 232
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19 228
Synthesis and biological evaluation of diastereoisomerically pure N,O-nucleosides 225
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 224
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 223
Modulation of neutrophil functions by activated platelet release factors 220
"Lab-on-a-Chip" devices for cellular array based on dielectrophoresis 218
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 217
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors 216
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 216
Phosphinic platinum complexes with 8-thiotheophylline derivatives: Synthesis, characterization, and antiproliferative activity 215
Vinyl ester-based cyclic peptide proteasome inhibitors 214
Deficiency of neutrophil membrane antigen detected by monoclonal antibody in rheumatoid arthritis 213
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 213
Rational design of nucleoside-bile acid conjugates incorporating a triazole moiety for anticancer evaluation and SAR exploration 212
Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8 212
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 210
New class of proteasome 20S inhibitors: a crystallographic and molecular modelling study 210
UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion 208
An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins 206
Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells 206
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 204
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 204
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 204
Dual mechanism in induction of human neutrophil cytotoxicity: Activation of protein kinase C and elevation in intracellular calcium 202
Attivita' tumoricida dei neutrofili 202
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 202
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 201
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 201
Different expression of Blimp-1 in HIV infection may be used to monitor disease progression and provide a clue to reduce immune activation and viral reservoirs 196
A new approach to UV protection by direct surface functionalization of TiO2 with the antioxidant polyphenol dihydroxyphenyl benzimidazole carboxylic acid 196
Platinum and ruthenium complexes of new long-tail derivatives of PTA (1,3,5-triaza-7-phosphaadamantane): Synthesis, characterization and antiproliferative activity on human tumoral cell lines 194
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (ii) carboxylates 193
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 192
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 190
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 190
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 189
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 189
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans 189
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 186
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120 185
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 185
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 183
null 183
CULTURED HUMAN FIBROBLASTS ACQUIRE ADHESIVENESS FOR NEUTROPHILS AFTER STIMULATION 182
Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells 182
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 181
ANTI-INFLAMMATORY AGENTS INHIBIT NEUTROPHIL CYTOTOXIC ACTIVITY TOWARDS ERYTHROLEUKEMIC HUMAN CELLS 181
Novel oleanolic vinyl boronates: synthesis and antitumor activity 180
Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2 179
null 179
"Lethal kiss” on a dielectrophoresis (DEP) based Lab-on-a-chip device: two-colour real-time determination of cytotoxic T-lymphocyte activity. 178
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 176
The Enigma of Tripeptidyl-Peptidase II: Dual Roles in Housekeeping and Stress 176
ACTION MECHANISM OF ACTIVATORS OF NEUTROPHIL-MEDIATED CYTOTOXICITY 174
ACTIVATED HUMAN FIBROBLASTS ADHERE TO NEUTROPHILS 174
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TOWARDS LINEAR AND CYCLIC PEPTIDE T ANALOG 173
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 173
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 172
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 171
HLA B51 antigen associated with neutrophil hyper-reactivity 168
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 168
Expression and functional A3 adenosine receptors in human lymphocytes 167
null 167
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 167
Dielectrophoresis (DEP) based Lab-on-a-chip devices for real-time monitoring of the activity of cytotoxic T-lymphocytes. 166
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 164
Expression and functionality of adenosine receptors in human blood cells 162
Expression of functional A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. 161
Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit 157
alpha,beta-Unsaturated Carbonyl System of Chalcone-Based Derivatives Is Responsible for Broad Inhibition of Proteasomal Activity and Preferential Killing of Human Papilloma Virus (HPV) Positive Cervical Cancer Cells 156
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 155
ACTIVATION OF NEUTROPHIL CYTOTOXICITY BY SYNERGISTIC ACTION OF TPA AND TARGET IMMUNIZATION 154
The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity 153
HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors 153
Vaccines containing the HIV tat protein as an adjuvant for the enhancement of cytotoxic T-cell responses 152
New cyclic peptide proteasome inhibitors 151
Triggering of neutrophil cytotoxicity against an antibody-coated tumour target by TPA 150
c-Myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells 148
NEUTROPHIL CR1 RECEPTOR: RELATIONSHIP BETWEEN EXPRESSION LEVEL AND CYTOTOXICITY IN HEALTHY AND CHRONIC MYELOID LEUKEMIA 147
HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population 146
Recent Advances In The Development Of HIV-1 Tat-Based Vaccines 146
Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides 146
Protein kinase C mediates human neutrophil cytotoxicity 144
Immune escape by Epstein-Barr virus (EBV) carrying burkitt's lymphoma: In vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells 144
Totale 19.801
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 935
Totale 117.369
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021123 0 0 0 0 0 0 0 0 0 0 0 123
2021/20221.776 53 158 154 112 93 58 116 96 75 119 151 591
2022/20231.594 168 84 78 215 254 230 84 133 192 10 84 62
2023/2024816 80 126 34 27 50 151 35 61 11 22 17 202
2024/20253.436 82 78 290 162 442 303 64 176 580 339 512 408
2025/20269.979 1.093 344 987 1.212 1.416 737 1.227 531 895 1.019 404 114
Totale 27.347